Seizert Capital Partners LLC Reduces Stock Position in CVS Health Corp (NYSE:CVS)

Seizert Capital Partners LLC lessened its position in shares of CVS Health Corp (NYSE:CVS) by 8.3% during the 2nd quarter, Holdings Channel reports. The firm owned 482,119 shares of the pharmacy operator’s stock after selling 43,696 shares during the quarter. Seizert Capital Partners LLC’s holdings in CVS Health were worth $26,271,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the business. Bay Harbor Wealth Management LLC raised its holdings in shares of CVS Health by 1,871.4% during the first quarter. Bay Harbor Wealth Management LLC now owns 552 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 524 shares during the last quarter. Centaurus Financial Inc. boosted its position in shares of CVS Health by 570.8% during the first quarter. Centaurus Financial Inc. now owns 1,630 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 1,387 shares during the period. Manchester Financial Inc. acquired a new stake in CVS Health in the second quarter valued at $31,000. Hudock Capital Group LLC raised its stake in CVS Health by 54.0% in the second quarter. Hudock Capital Group LLC now owns 576 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 202 shares in the last quarter. Finally, Executive Wealth Management LLC increased its position in shares of CVS Health by 62.4% during the second quarter. Executive Wealth Management LLC now owns 565 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 217 shares in the last quarter. Institutional investors and hedge funds own 75.20% of the company’s stock.

Shares of NYSE:CVS traded down $1.81 during trading on Friday, hitting $60.24. 7,757,375 shares of the stock were exchanged, compared to its average volume of 9,365,758. The company has a fifty day moving average price of $57.32 and a two-hundred day moving average price of $56.33. The company has a market cap of $80.18 billion, a PE ratio of 8.51, a P/E/G ratio of 1.35 and a beta of 0.90. The company has a current ratio of 0.95, a quick ratio of 0.64 and a debt-to-equity ratio of 1.39. CVS Health Corp has a 12-month low of $51.72 and a 12-month high of $82.15.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.89 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.70 by $0.19. CVS Health had a return on equity of 16.15% and a net margin of 1.91%. The business had revenue of $63.43 billion for the quarter, compared to analyst estimates of $62.66 billion. During the same quarter in the previous year, the company earned $1.69 EPS. The company’s quarterly revenue was up 35.2% on a year-over-year basis. Equities research analysts anticipate that CVS Health Corp will post 6.96 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Friday, August 2nd. Investors of record on Thursday, July 25th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 3.32%. The ex-dividend date was Wednesday, July 24th. CVS Health’s payout ratio is currently 28.25%.

A number of research firms have recently commented on CVS. Mizuho set a $71.00 target price on CVS Health and gave the stock a “buy” rating in a research report on Wednesday, June 5th. BMO Capital Markets set a $63.00 target price on CVS Health and gave the stock a “hold” rating in a research report on Friday, May 3rd. Citigroup lifted their target price on CVS Health from $68.00 to $72.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. Standpoint Research upgraded CVS Health from a “hold” rating to a “buy” rating in a research report on Wednesday, June 5th. Finally, Evercore ISI set a $63.00 target price on CVS Health and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $75.14.

CVS Health Company Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Recommended Story: What are popular green investing opportunities?

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.